Commercial Consulting Services
Combining Clarivate’s robust proprietary data with extensive bespoke consulting advisory and custom research and analytics capabilities, we develop nuanced, defendable assessments and strategies to help biopharmaceutical and medtech clients make better, more informed decisions in a rapidly changing landscape.
By harnessing deep domain knowledge, proprietary data sets, and broad methodological capabilities, we provide innovative problem-solving approaches to biopharma and medtech’s toughest challenges. Our pioneering insight-enabled consulting model sets us apart, empowering us to focus on co-creation, thought partnership, and custom solutions.
We help our clients across four major pillars of the product lifecycle.
New product and portfolio strategy
Developing an approach that maximizes product and portfolio impact requires a detailed, nuanced understanding of disease area and industry dynamics. We empower our clients to seize market opportunities and craft winning product and portfolio strategies.
Backed by deep domain knowledge and extensive experience from proof of concept through lifecycle management, our team delivers strategic, data-driven recommendations to support clinical development, enable effective product positioning, and fuel successful market adoption.
Offerings include:
- Therapy Area Strategy
- New Market Entry Strategy
- Growth and Value Maximization Strategy
- Portfolio Optimization and Prioritization
- Market, TA, Indication and Asset Opportunity Assessments
- TPP Development and Testing
- Demand Studies / Forecasting
- Positioning / Competitive Differentiation Strategy
- Integrated Patient Journey
- Site of Care Analysis
- BD&L Target Search
- Commercial Due Diligence
Clinical, economic and real-world evidence
We provide technical consulting and expertise across the product journey, helping our clients maximize the value of their available evidence and addressing gaps to support successful access and reimbursement strategies within their target markets.
Our team consists of technical experts including health economists, statisticians, medical writers, in-house graphic designers, commercial assessment analysts, systematic reviewers, and COA specialists, enabling us to provide bespoke, end-to-end solutions across the product lifecycle with the goal of optimizing market access.
Offerings include:
- Custom Epidemiology Studies
- RWE Study Design and Execution (Epi Studies, Registry Analysis, HCRU Analysis, Retrospective Chart Reviews, Prospective Studies)
- Early Analysis and Economic Modelling
- Clinical Outcomes Assessments (PROs and Patient Preference Studies)
- Core Global Economic Modelling (CEMs & BIMs)
- Systematic Literature Reviews and Network Meta-Analysis
Pricing and market access
Critical to the commercial success of a product is a detailed understanding of its market access potential. Our team’s extensive experience and proprietary data assets enable us to guide our clients through the evolving complexities of global reimbursement markets with thoughtful consideration of the unique dynamics at play. We empower our clients to understand regulatory and payer trends, evidence requirements, and innovative strategies for optimizing pricing and market access.
Offerings include:
- Access Landscapes and Account Journey Pathways
- Indication Prioritization
- TPP Development and Testing
- Gap Analysis and Evidence Generation Strategy
- Launch Pricing
- Payer / Account Archetyping, Segmentation and Engagement Planning
- Contracting and Formulary
- Placement Strategy and Simulation
- Mock Negotiation Workshops
- HTA Submissions and Support
Customer strategy and commercialization practice
We help life science and pharma leaders to bring innovation to patients and accelerate performance by connecting deep market insight with strategic clarity and execution excellence.
From launch preparation to loss of exclusivity, we support clients in understanding markets, shaping customer first strategies, identifying commercialization needs and driving impactful engagement across global, regional and local levels.
Offerings include:
- Launch preparation and commercial readiness
- Customer segmentation, targeting and profiling
- Integrated patient journey mapping
- Brand strategy and execution plan
- Competitive simulation (‘wargaming’)
- Go-to-market model
- Customer-facing organization design and transformation
- Commercial and marketing excellence
- Customer experience and omnichannel
- Social media listening
- Competitive intelligence
- Brand and customer-facing team performance
- Digital messaging at Point of Care (bespoke solution)
599k+
300m+
40
Check out our latest webinars
Pinpoint your ideal patient and address true patients’ needs through discovering and designing treatments with comprehensive scientific and clinical intelligence.
Our latest thought leadership
U.S. market access landscape: A push for control is erasing the boundary between payers and providers in U.S. healthcare
Major U.S. healthcare payers and providers are consolidating at a dizzying clip as they seek to gain market share, increase access to care and secure clinical control to improve health…
